| 4.6 |
13.7 |
GO:0021529 |
spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 2.0 |
12.1 |
GO:0010624 |
regulation of Schwann cell proliferation(GO:0010624) |
| 1.7 |
5.1 |
GO:0042560 |
10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 1.7 |
5.1 |
GO:2000501 |
natural killer cell chemotaxis(GO:0035747) negative regulation of lymphocyte migration(GO:2000402) regulation of natural killer cell chemotaxis(GO:2000501) |
| 1.6 |
4.9 |
GO:0003278 |
apoptotic process involved in heart morphogenesis(GO:0003278) |
| 1.4 |
4.3 |
GO:1900020 |
ovarian follicle rupture(GO:0001543) angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) establishment of blood-nerve barrier(GO:0008065) regulation of activation of Janus kinase activity(GO:0010533) regulation of activation of JAK2 kinase activity(GO:0010534) regulation of amino acid import(GO:0010958) regulation of L-arginine import(GO:0010963) response to muscle activity involved in regulation of muscle adaptation(GO:0014873) regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) regulation of membrane hyperpolarization(GO:1902630) |
| 1.4 |
9.8 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) |
| 1.4 |
8.3 |
GO:0000050 |
urea cycle(GO:0000050) urea metabolic process(GO:0019627) |
| 1.3 |
4.0 |
GO:0048818 |
positive regulation of hair follicle maturation(GO:0048818) positive regulation of catagen(GO:0051795) |
| 1.2 |
4.9 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 1.2 |
6.0 |
GO:1903026 |
negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 1.1 |
5.6 |
GO:0044838 |
cell quiescence(GO:0044838) |
| 1.0 |
7.0 |
GO:0010273 |
detoxification of copper ion(GO:0010273) cellular response to zinc ion(GO:0071294) stress response to copper ion(GO:1990169) |
| 1.0 |
2.9 |
GO:0002430 |
complement receptor mediated signaling pathway(GO:0002430) |
| 0.8 |
5.8 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.8 |
4.9 |
GO:0042535 |
positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
| 0.8 |
4.9 |
GO:0042590 |
antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.8 |
4.9 |
GO:0043415 |
positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
| 0.8 |
2.3 |
GO:0001951 |
intestinal D-glucose absorption(GO:0001951) terminal web assembly(GO:1902896) |
| 0.7 |
2.2 |
GO:1901896 |
positive regulation of calcium-transporting ATPase activity(GO:1901896) |
| 0.7 |
2.0 |
GO:1904139 |
microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
| 0.6 |
1.7 |
GO:0050929 |
corticospinal neuron axon guidance through spinal cord(GO:0021972) positive regulation of negative chemotaxis(GO:0050924) induction of negative chemotaxis(GO:0050929) negative regulation of mononuclear cell migration(GO:0071676) negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
| 0.6 |
2.3 |
GO:0045091 |
regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
| 0.6 |
3.3 |
GO:0030913 |
paranodal junction assembly(GO:0030913) |
| 0.6 |
1.7 |
GO:2000416 |
regulation of eosinophil migration(GO:2000416) positive regulation of eosinophil migration(GO:2000418) |
| 0.5 |
1.6 |
GO:1902310 |
positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.5 |
2.1 |
GO:0031509 |
telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
| 0.5 |
1.5 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.5 |
1.0 |
GO:0042414 |
epinephrine metabolic process(GO:0042414) |
| 0.5 |
7.7 |
GO:0035994 |
response to muscle stretch(GO:0035994) |
| 0.4 |
1.3 |
GO:0035519 |
protein K29-linked ubiquitination(GO:0035519) |
| 0.4 |
2.6 |
GO:0043137 |
DNA replication, removal of RNA primer(GO:0043137) |
| 0.4 |
1.2 |
GO:0002842 |
T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) positive regulation of T cell mediated immune response to tumor cell(GO:0002842) transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.4 |
1.9 |
GO:1902255 |
positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 0.4 |
0.7 |
GO:0060455 |
negative regulation of gastric acid secretion(GO:0060455) |
| 0.4 |
1.4 |
GO:0006407 |
rRNA export from nucleus(GO:0006407) |
| 0.3 |
2.4 |
GO:0035948 |
positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
| 0.3 |
1.3 |
GO:0044650 |
virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) |
| 0.3 |
2.5 |
GO:0045842 |
positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
| 0.3 |
11.8 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.3 |
9.4 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.3 |
1.5 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 0.3 |
0.9 |
GO:0006059 |
hexitol metabolic process(GO:0006059) |
| 0.3 |
1.2 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.3 |
1.7 |
GO:0090091 |
positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.3 |
5.0 |
GO:0021521 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.3 |
0.8 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) endothelial cell-cell adhesion(GO:0071603) negative regulation of monocyte chemotaxis(GO:0090027) |
| 0.3 |
1.6 |
GO:1904936 |
cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 0.2 |
1.7 |
GO:0016560 |
protein import into peroxisome matrix, docking(GO:0016560) |
| 0.2 |
5.8 |
GO:0045662 |
negative regulation of myoblast differentiation(GO:0045662) |
| 0.2 |
0.9 |
GO:0071442 |
positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.2 |
1.6 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.2 |
1.6 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.2 |
0.7 |
GO:0034124 |
regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
| 0.2 |
4.0 |
GO:0019430 |
removal of superoxide radicals(GO:0019430) |
| 0.2 |
1.6 |
GO:0014807 |
regulation of somitogenesis(GO:0014807) |
| 0.2 |
0.6 |
GO:1903225 |
regulation of endodermal cell fate specification(GO:0042663) negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.2 |
1.2 |
GO:1902847 |
macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of tau-protein kinase activity(GO:1902949) |
| 0.2 |
0.8 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.2 |
0.9 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 0.2 |
1.4 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
| 0.2 |
4.7 |
GO:0071353 |
cellular response to interleukin-4(GO:0071353) |
| 0.2 |
3.0 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.2 |
2.4 |
GO:0050765 |
negative regulation of phagocytosis(GO:0050765) |
| 0.1 |
0.7 |
GO:0030299 |
intestinal cholesterol absorption(GO:0030299) |
| 0.1 |
2.0 |
GO:0043402 |
glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.1 |
1.4 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.1 |
3.3 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.1 |
0.4 |
GO:0070944 |
neutrophil mediated killing of bacterium(GO:0070944) |
| 0.1 |
1.7 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.1 |
1.0 |
GO:0000712 |
resolution of meiotic recombination intermediates(GO:0000712) |
| 0.1 |
1.7 |
GO:0071624 |
positive regulation of granulocyte chemotaxis(GO:0071624) positive regulation of neutrophil chemotaxis(GO:0090023) |
| 0.1 |
0.7 |
GO:0061635 |
regulation of protein complex stability(GO:0061635) |
| 0.1 |
1.0 |
GO:0042573 |
retinoic acid metabolic process(GO:0042573) |
| 0.1 |
0.7 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.1 |
0.9 |
GO:0070234 |
positive regulation of T cell apoptotic process(GO:0070234) |
| 0.1 |
1.1 |
GO:0038063 |
collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.1 |
0.7 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.1 |
0.6 |
GO:1902416 |
positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
| 0.1 |
0.3 |
GO:0001580 |
detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.1 |
4.5 |
GO:0001756 |
somitogenesis(GO:0001756) |
| 0.1 |
1.5 |
GO:1900153 |
regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.1 |
4.2 |
GO:0072661 |
protein targeting to plasma membrane(GO:0072661) |
| 0.1 |
1.4 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
| 0.1 |
0.5 |
GO:0090394 |
negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 0.1 |
0.4 |
GO:0006046 |
N-acetylglucosamine catabolic process(GO:0006046) |
| 0.1 |
0.5 |
GO:0002002 |
regulation of angiotensin levels in blood(GO:0002002) |
| 0.1 |
1.2 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.1 |
1.9 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.1 |
0.3 |
GO:0010730 |
negative regulation of hydrogen peroxide metabolic process(GO:0010727) negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 0.1 |
1.1 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.1 |
0.2 |
GO:0035356 |
cellular triglyceride homeostasis(GO:0035356) |
| 0.1 |
3.4 |
GO:0030500 |
regulation of bone mineralization(GO:0030500) |
| 0.1 |
0.2 |
GO:0046340 |
diacylglycerol catabolic process(GO:0046340) |
| 0.1 |
0.4 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.0 |
1.2 |
GO:0006730 |
one-carbon metabolic process(GO:0006730) |
| 0.0 |
0.7 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 0.0 |
0.9 |
GO:0097286 |
iron ion import(GO:0097286) |
| 0.0 |
0.4 |
GO:0060965 |
negative regulation of gene silencing by miRNA(GO:0060965) |
| 0.0 |
0.5 |
GO:0031987 |
locomotion involved in locomotory behavior(GO:0031987) |
| 0.0 |
0.6 |
GO:0010640 |
regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
| 0.0 |
7.2 |
GO:0051480 |
regulation of cytosolic calcium ion concentration(GO:0051480) |
| 0.0 |
0.4 |
GO:1903427 |
negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
| 0.0 |
0.8 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.0 |
1.6 |
GO:0022904 |
respiratory electron transport chain(GO:0022904) |
| 0.0 |
0.7 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.0 |
2.0 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 0.0 |
0.7 |
GO:0032410 |
negative regulation of transporter activity(GO:0032410) |
| 0.0 |
0.5 |
GO:0001539 |
cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
| 0.0 |
1.3 |
GO:0030521 |
androgen receptor signaling pathway(GO:0030521) |
| 0.0 |
1.1 |
GO:0033119 |
negative regulation of RNA splicing(GO:0033119) |
| 0.0 |
0.4 |
GO:0071470 |
cellular response to osmotic stress(GO:0071470) |
| 0.0 |
0.7 |
GO:0034629 |
cellular protein complex localization(GO:0034629) |
| 0.0 |
1.3 |
GO:0031338 |
regulation of vesicle fusion(GO:0031338) |
| 0.0 |
0.2 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.0 |
0.7 |
GO:0030819 |
positive regulation of cAMP biosynthetic process(GO:0030819) |
| 0.0 |
0.6 |
GO:0006414 |
translational elongation(GO:0006414) |
